Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Retained Earnings (2020 - 2025)

Historic Retained Earnings for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to -$109.2 million.

  • HCW Biologics' Retained Earnings fell 1240.16% to -$109.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$109.2 million, marking a year-over-year decrease of 1240.16%. This contributed to the annual value of -$100.6 million for FY2024, which is 4256.75% down from last year.
  • HCW Biologics' Retained Earnings amounted to -$109.2 million in Q3 2025, which was down 1240.16% from -$104.7 million recorded in Q2 2025.
  • Over the past 5 years, HCW Biologics' Retained Earnings peaked at -$23.2 million during Q2 2021, and registered a low of -$109.2 million during Q3 2025.
  • Its 5-year average for Retained Earnings is -$64.3 million, with a median of -$57.4 million in 2023.
  • Per our database at Business Quant, HCW Biologics' Retained Earnings crashed by 8325.0% in 2021 and then crashed by 1222.14% in 2025.
  • Over the past 5 years, HCW Biologics' Retained Earnings (Quarter) stood at -$30.6 million in 2021, then crashed by 48.64% to -$45.5 million in 2022, then plummeted by 54.89% to -$70.5 million in 2023, then crashed by 42.57% to -$100.6 million in 2024, then dropped by 8.63% to -$109.2 million in 2025.
  • Its last three reported values are -$109.2 million in Q3 2025, -$104.7 million for Q2 2025, and -$102.8 million during Q1 2025.